Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study

Maeve E. Wickham,Kimberlyn M. McGrail,Michael R. Law,Amber Cragg,Corinne M. Hohl
DOI: https://doi.org/10.1002/pds.70012
2024-09-21
Pharmacoepidemiology and Drug Safety
Abstract:Purpose The magnitude of repeat exposures to culprit medications after hospital discharge is not well studied. We combined prospective cohort data with administrative health data to understand the frequency of repeat exposures to culprit medications after discharge and the risk factors for their occurrence. Methods This was a retrospective analysis of three prospective cohorts of patients who presented to the hospital with an adverse drug event in British Columbia, from 2008 to 2015 (n = 849). We linked prospectively identified adverse drug events to administrative data to examine patterns of redispensing of culprit medications. We used Cox regression to assess risk factors for re‐exposure, and conducted subgroup analyses for essential vs. nonessential medications. Results Among 849 diagnosed adverse drug events, 45.2% had subsequent culprit medication redispensing within a year of hospital discharge. The factors associated with re‐exposures included atrial fibrillation, adverse drug event type (e.g. adverse reaction), culprit medication type, and longer historical duration of medication use. Conclusions Re‐exposures to culprit medications occurred in almost half of the adverse drug events diagnosed in emergency departments. Many of these were appropriate re‐exposures to essential medications for indications in which the risk of uncontrolled disease likely outweighed the risk of a repeat adverse event. More research is needed to understand re‐exposures to nonessential medications or medications with safer alternatives.
pharmacology & pharmacy,public, environmental & occupational health
What problem does this paper attempt to address?